TABLE 3.
Selected laboratory values in men and women following 4-wk feeding periods for control (0 g/d HAM-RS2), 15 g/d HAM-RS2, and 30 g/d HAM-RS21
| Variable2 | Control | 15 g/d HAM-RS2 | 30 g/d HAM-RS2 | P |
| Men | ||||
| n | 11 | 11 | 11 | |
| ln hsCRP, mg/L | 0.4 ± 0.2 (1.4) | 0.2 ± 0.2 (1.2) | 0.4 ± 0.2 (1.4) | 0.33 |
| Adiponectin, mg/L | 5.9 ± 0.6 | 5.8 ± 0.6 | 5.6 ± 0.6 | 0.70 |
| Fructosamine, μmol/L | 198 ± 6 | 198 ± 6 | 197 ± 6 | 0.98 |
| ln HOMA%B | 4.4 ± 0.1 (78.1) | 4.1 ± 0.1 (61.5) | 4.3 ± 0.1 (70.3) | 0.18 |
| ln HOMA%S | 4.6 ± 0.1 (97.7) | 4.7 ± 0.1 (115) | 4.6 ± 0.1 (96.4) | 0.38 |
| Fasting insulin, pmol/L | 62.5 ± 4.7 | 50.1 ± 4.7 | 58.5 ± 4.7 | 0.15 |
| ln Fasting glucose, mmol/L | 1.7 ± 0.1 (5.4) | 1.8 ± 0.8 (5.8) | 1.8 ± 0.22 (5.7) | 0.40 |
| Women | ||||
| n | 22 | 21 | 22 | |
| ln hsCRP, mg/L | 0.8 ± 0.2 (2.1) | 0.5 ± 0.2 (1.6) | 0.7 ± 0.2 (2.1) | 0.32 |
| ln Adiponectin, mg/L | 2.3 ± 0.1 (10.4) | 2.4 ± 0.1 (10.9) | 2.4 ± 0.1 (10.6) | 0.30 |
| Fructosamine, μmol/L | 207 ± 4 | 205 ± 4 | 206 ± 4 | 0.70 |
| HOMA%B | 89.3 ± 6.1 | 84.2 ± 6.2 | 80.7 ± 6.1 | 0.38 |
| ln HOMA%S | 4.5 ± 0.1 (91.1) | 4.6 ± 0.1 (97.6) | 4.7 ± 0.1 (113) | 0.10 |
| Fasting insulin, pmol/L | 56.2 ± 4.9 | 51.6 ± 5.0 | 47.5 ± 4.9 | 0.25 |
| Fasting glucose, mmol/L | 5.5 ± 0.1 | 5.5 ± 0.1 | 5.4 ± 0.1 | 0.29 |
1
Data presented as least squares means ± SEM, (geometric least squares means). Means in a row with superscripts without a common letter differ, < 0.05. AIRG, acute insulin response to i.v. glucose; HAM-RS2, high-amylose maize type 2 resistant starch; HOMA%B, homeostasis model assessment of β-cell function; HOMA%S, homeostasis model assessment of insulin sensitivity; hsCRP, high-sensitivity CRP; SG, glucose effectiveness;
2
All outcomes were measured in plasma, except for hsCRP which was measured in serum.